Biotech company Imperagen announced on Thursday a ยฃ5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.

Posted inNews

Biotech company Imperagen announced on Thursday a ยฃ5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.
This is an exciting development for Imperagen! The combination of quantum physics and AI in enzyme engineering could lead to some groundbreaking advancements in biotechnology. Looking forward to seeing how this unfolds!